Critical review of treatment trials in hypertension |
| |
Authors: | JIS ROBERTSON |
| |
Affiliation: | Elmbank, Manse Road, Bowling, Glasgow, United Kingdom |
| |
Abstract: | Summary: Despite numerous deficiencies in some antihypertensive drug treatment trials, and some questionable selections of studies for inclusion in several meta-analyses, undoubtedly such trials have shown treatment benefits from reducing hypertension. Complications that can be corrected or prevented include malignant hypertension, hypertensive heart failure, stroke and coronary artery morbidity. the all-cause mortality has been lowered in several trials. the benefits have been seen in subjects aged over 60 years, in women and men, and in patients with isolated systolic hypertension. the benefits have been achieved using a wide range of drugs, not only with beta-blockers or diuretics. Non-pharmacological means of lowering blood pressure have not been evaluated in relation to morbidity. |
| |
Keywords: | antihypertensive drugs coronary disease elderly patients heart failure meta-analysis stroke systolic hypertension treatment trials |
|
|